Belatacept and Molecular Biomarkers: A Panel Discussion

Jul 23, 2025, 7:00 PM EDT

Explore the role of molecular biomarkers in immunosuppression management with three leading experts in the field of transplant medicine. Don't miss this opportunity to gain valuable insights for your practice and participate in this dynamic fireside chat.

Belatacept and Molecular Biomarkers: The Role of Molecular Biomarkers in Immunosuppression Management at UT Southwestern

Hear from David Wojciechowski, D.O.,the Medical Director for the Kidney Transplantation Program UT Southwestern in Dallas as he walks through his use of molecular biomarkers for patients treated with Belatacept.

Belatacept and Molecular Biomarkers: The Role of Molecular Biomarkers in Immunosuppression Management at Froedert and Medical

Hear from Dr. Beje Thomas, Adult Kidney and Pancreas Transplant Medical Director, as he walks through his use of molecular biomarkers for patients treated with Belatacept.

Belatacept and Molecular Biomarkers: The Role of Molecular Biomarkers in Immunosuppression Management at UCLA

Hear from Dr. Suphamai Bunnapradist, Professor of Medicine at UCLA as he walks through his use of molecular biomarkers for patients treated with Belatacept.

Biomarkers with Discordant Results: Theoretical Workflow for Practical Use

Post-transplant kidney recipient monitoring has dramatically changed in the last few years. The addition of gene expression profiling with TruGraf kidney and ddcfDNA assessment augmented with infectious disease tracking with TRAC provides clinicians with cutting edge tools. But what happens when these two tests disagree with one another? The Chair of the Department of Transplantation and Liver Surgery at Geisinger Health System and a Professor of Surgery at Geisinger Commonwealth School of Medicine.

Fungal Infections in Transplant Recipients: A Case-Based Approach

Join us for a case-based webinar on the critical role of rapid fungal infection detection in transplant recipients. Dr. Daniel Z. Friedman, MD, will showcase real-world examples demonstrating how rapid PCR testing enhances clinical decision-making and improves patient outcomes. Learn how timely diagnostic insights can support effective treatment when every moment counts. Don’t miss this opportunity to explore cutting-edge testing solutions that can make a life-saving difference.

Watch the Webinar featuring Daniel Z. Friedman, MD

Tailoring CMV Prophylaxis Based On T Cell Immunity Panel Assessment in Kidney Transplant Patients at High Risk of CMV

Join us for an insightful on-demand webinar featuring Abigail Servais, PharmD, BCTXP, and Steve Kleiboeker, PhD, as they delve into a groundbreaking protocol at an academic medical center. This protocol incorporates serial assessment of CMV T Cell Immunity Panel (CMV-TCIP) to tailor valganciclovir prophylaxis duration for high-risk kidney transplant patients. Discover their findings on the risk of CMV disease following early discontinuation of prophylaxis and the predictors identified through CMV T cell immunity assessment.

Watch the Webinar featuring Abigail Servais, PharmD

TTV Torque Teno Virus Immunologic Monitoring

View this engaging webinar hosted by Eurofins Viracor, exploring the potential of Torque Teno Virus (TTV) as a biomarker for immune function. TTV plasma load has been shown to reflect the host’s immune status, making it a valuable tool for immunologic monitoring.

Watch the Webinar featuring Gregor Bond, MD, PhD

Medical Mycology 2024: What's New

Join us for an insightful presentation by Dr. Luis Ostrosky-Zeichner, MD, where we explore the latest advancements and emerging trends in the field of medical mycology. The discussion covers critical topics such as current epidemiological data, evolving nomenclature standards, and recent innovations in antifungal treatments. Additionally, the video delves into the necessity for new diagnostic methods to keep pace with novel drugs and examines the evolving practices in clinical trial conduct. Join us for a comprehensive update on where medical mycology stands today and what the future holds.

Watch the Webinar featuring Luis Ostrosky, MD

All About OmniGraf™ Liver

Transplant Genomics is proud to announce the release of OmniGraf™ Liver, the first and only non-invasive diagnostic test that provides guidance for controlled reduction of immunosuppression to optimize therapy in liver transplant recipients.

This innovative test provides a score for patients to assess their risk of rejection. OmniGraf™ Liver grades a patient on their risk for rejection, providing a numerical output for patients at high or low risk inclusive of patients that match the phenotype of acute dysfunction of the liver without the presence of rejection. Utilizing molecular biomarkers and advanced bioinformatics, OmniGraf™ Liver also allows for the controlled reduction of immunosuppressant therapy in three easy steps. OmniGraf™ Liver features a negative predictive value of 93%, internally validated using patient data from the CTOT-14 trial.

Watch the Webinar featuring our Vice President of Research and Development, Dr. Steve Kleiboeker, explain the science behind the test, and what to expect with this innovation!

Treating Subclinical Rejection Series

Watch this important webinar on Treating Subclinical Rejection featuring Dr. John Friedewald, Dr. Michael Marvin, and Dr. Namita Singh, as they delve into the complexities of treating subclinical rejection in kidney transplantation.

This webinar offers a unique opportunity to gain insights from a panel of experts who bring a wealth of knowledge and experience to the table. Together, they will explore the latest advancements in identifying and managing subclinical rejection, drawing from their combined expertise in both research and clinical practice.

Eurofins Transplant Diagnostics is dedicated to meeting the needs of transplant patients and providers throughout the entire transplant journey, from pre- to post-transplant, with testing solutions that can do just that.